This is rather intriguing as MEK inhibitors including trametinib is associated with acneiform dermatitis, owing to off-target effects on KLF4/NF-κB-dependent transcription of inflammatory cytokines (57). This evidence concerns the gene KLF4 and acneiform dermatitis.